Prognostic value of bone marrow angiogenesis in multiple myeloma: Use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters

American Journal of Hematology

Volumn 81, Issue 9, 2006, Pages 649-656

  Bhatti, Sahibinder Singh ^a,c   Kumar, Lalit ^b   Dinda, Amit Kumar ^a   Dawar, Ramesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c NONE   (India)

Author keywords

Angiogenesis; Computerized image analysis; Microvessel density; Multiple myeloma; Prognosis; Total vascular area

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CLINICAL FEATURE; COMPUTER ANALYSIS; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MICROVASCULATURE; MULTIPLE MYELOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 33748108569     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20639     Document Type: Article

References (35)

1. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis N Engl J Med 1995;333:1557-1563.
2. Fox SB. Tumor angiogenesis and prognosis. Histopathology 1997;30:294-301.
3. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Rajkumar SV, Fonseca R, Witzig TE, et al. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 1999;13:469-472.
5. Perez-Atayele AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150:815-821.
6. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics 2000. CA Cancer J Clin 2000;50:7-33.
7. Bataille R, Harousseau JLS. Multiple myeloma. N Engl J Med 1997;336:1657-1664.
8. Verma K, Tyagi BB, George J. Population based cancer registry, Delhi (IRCH, AIIMS). Individual registry data: 1990-1996;200-203.
9. Kumar L, Wadhwa J, Kochupillai V. Multiple myeloma: recent advances: Indian J Hematol Blood Trans 2001;19:11-16.
10. Jyoti Wadhwa: Multiple myeloma. A retrospective analysis of 534 patients. DM dissertation. Department of Medical Oncology, AIIMS, December 1999.
11. Munshi N, Wilson CS, Penn J, et al. Angiogenesis in newly diagnosed multiple myeloma: poor prognosis with increased microvessel density (MVD) in bone marrow biopsies. Blood 1998;92(Suppl 1):98a.
12. Munshi NC, Wilson C. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol 2001;28:565-569.
13. Rajkumar SV, Kyle RA. Angiogenesis in multiple myeloma. Sem Oncol 2001;28:560-564.
14. Vacca A, Ribatti D, Roccaro AM, et al. Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 2001;28:543-550.
15. Kumar S, Fonseca R, Dispenzieri A, et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol 2002;119:665-671.
16. Manzoor HM, Adrian CN. Review: angiogenesis and angiogenic mediators in hematological malignancies. Br J Haematol 2000;111:43-51.
17. Vacca A, Di Loreto M, Ribatti D, et al. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol 1995;50:9-14.
18. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503-508.
19. Rajkumar SV, Leong T, Roche PC, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000;6:3111-3116.
20. Sezer O, Niemoller K, Eucker J, et al. Bone marrow microvessel density is a prognostic factor for survival in-patients with multiple myeloma. Ann Hematol 2000;79:574-577.
21. Rajkumar SV, Fonseca R, Ansell SM, Witzig TE, Gertz MA, Greipp PR. Computerized image analysis in the assessment of bone marrow angiogenesis in multiple myeloma. Blood 1998;92(Suppl I):100a.
22. Durie BG, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975;36:842.
23. Bartl R, Frisch B, Fateh Moghadam A, Kettner G, Jaeger K. Histological classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87:342-355.
24. Ahn MJ, Park CK, Choi JH. Clinical significance of microvessel density in multiple myeloma patient. J Korean Med Sci 2001;16:45-50.
25. Salmon SE, Robert Cassidy J. Plasma cell neoplasms. In: Cancer: principles and practice of oncology, 6th ed. De Vita VT, Hellman S, Rosenberg SA, editors. Philadelphia: Lippincott, 2001.
26. Cavo M, Baccarani M, Gobbi M, et al. Bone marrow plasma cell infiltration in multiple myeloma. Br J Haematol 1984;57:352-353.
27. Pasqualetti P, Casale R, Callacciani A, Calantonio D. Prognostic factors in multiple myeloma: a new staging system based on clinical and morphological features. Eur J Cancer 1991;27:1123-1126.
28. 2 microglobulin in multiple myeloma: a simple reliable marker for staging. Br J Haematol 1983;55:439-447.
29. Bataille R, Durie BGM, Grenier J, et al. Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 1986;4:80-87.
30. Björkstrand B, Goldstone A, Jjungman P, et al. Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. Leuk Lymphoma 1994;15:265-272.
31. Vesole DH, Barlogie B, Jagannath S, et al. High dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994;84:950-956.
32. Vesole D, Tricot G, Jagannath S, et al. Autotransplantation in multiple myeloma: what have we learned? Blood 1996;88:838-847.
33. Marit G, Faberes C, Pico JL, et al. Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy in patients with high-risk multiple myeloma. J Clin Oncol 1996;14:1306-1313.
34. Jagannath S, Barlogie B, Dicke K, et al. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990;76:1860-1866.
35. Roddie PH, Dang R, Parker AC. Multiple myeloma in three siblings. Clin Lab Haematol 1998;20:191-193.